The WACC of Esperion Therapeutics Inc (ESPR) is 6.7%.
| Range | Selected | |
| Cost of equity | 7.50% - 10.50% | 9.00% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.9% - 7.6% | 6.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.8 | 1.01 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.50% | 10.50% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.74 | 0.74 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.9% | 7.6% |
| Selected WACC | 6.7% | |